• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 2.00% Nasdaq Up 1.66%

    Inovio Pharmaceuticals, Inc. (INO)

    -NasdaqGS
    6.27 Up 0.08(1.29%) Feb 12, 4:00PM EST
    |After Hours : 6.26 Down 0.01 (0.16%) Feb 12, 7:03PM EST
    Prev Close:6.19
    Open:6.22
    Bid:6.10 x 1200
    Ask:6.30 x 1300
    1y Target Est:20.20
    Beta:2.39284
    Earnings Date:Mar 14 - Mar 18 (Est.)
    Day's Range:6.03 - 6.32
    52wk Range:4.50 - 10.83
    Volume:1,547,059
    Avg Vol (3m):1,791,790
    Market Cap:452.59M
    P/E (ttm):N/A
    EPS (ttm):-0.30
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    INOUp 1.29%452.59M
    PFEUp 0.79%181.25B
    AZNUp 1.75%74.98B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):12.05
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.40
    Quarterly EPS Est (Dec-15) :-0.20
    Mean Recommendation*:1.6
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Inovio Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops active DNA immunotherapies and vaccines in combination with proprietary electroporation delivery devices to prevent and treat cancers and infectious diseases. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback